Ditropan and Zelnorm drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ditropan (oxybutynin chloride) and Zelnorm (tegaserod maleate). Common drug interactions include alanine aminotransferase increased among females and cerebral atrophy among males.
The phase IV clinical study analyzes what interactions people have when they take Ditropan and Zelnorm. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.
What is Ditropan?
Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.
What is Zelnorm?
Zelnorm has active ingredients of tegaserod maleate. eHealthMe is studying from 7,261 Zelnorm users. Check the latest studies of Zelnorm.
27 people who take Ditropan and Zelnorm together, and have interactions are studied.

What are the common drug interactions of Ditropan and Zelnorm, by gender? *:
female:
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Asthenia (weakness)
- Asthma
- Balance disorder
- Depression
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
- Diarrhoea
- Diarrhoea haemorrhagic (bloody diarrhoea)
- Drug ineffective
male:
- Cerebral atrophy (decrement in size of brain)
- Fatigue (feeling of tiredness)
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Atrial tachycardia (rhythm disturbance that arises in the atria)
- Balance disorder
- Brain stem haemorrhage (bleeding into structures of brain stem)
- Cardiac failure
- Carotid arteriosclerosis (plaque deposition in artery)
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Coronary artery disease (plaque building up along the inner walls of the arteries of the heart, which narrows the arteries and restricts blood flow to the heart)
What are the common drug interactions of Ditropan and Zelnorm, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
- Dyspnoea (difficult or laboured respiration)
- Throat tightness
- Hypersensitivity
- Infusion related reaction
- Pallor
- Respiratory distress (difficulty in breathing)
- Wheezing (a high-pitched whistling sound made while you breath)
40-49:
- Abdominal distension
- Abdominal pain
- Bone cyst
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Constipation
- Diabetes mellitus inadequate control
- Dizziness
- Dyspnoea (difficult or laboured respiration)
- Exostosis (formation of new bone on the surface of a bone)
- Foot deformity (functional disability of foot)
50-59:
- Tinnitus (a ringing in the ears)
- Diarrhoea haemorrhagic (bloody diarrhoea)
- Abdominal pain
- Abdominal tenderness
- Blood potassium decreased
- Chest pain
- Colitis (inflammation of colon)
- Colitis ischaemic (due to infection of intestine impaired blood supply to colon)
- Diarrhoea
- Extrasystoles
60+:
- Dizziness
- Balance disorder
- Dyspnoea (difficult or laboured respiration)
- Hypertension (high blood pressure)
- Intervertebral disc disorder (spinal disc disorder)
- Spinal disorder (disease of spine a back bone)
- Arrhythmia (irregular heartbeat)
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Atrial flutter (an abnormal heart rhythm that occurs in the atria of the heart)
- Atrial tachycardia (rhythm disturbance that arises in the atria)
What are the existing conditions these people have? *
- Irritable Bowel Syndrome: 6 people, 22.22%
- Pain: 4 people, 14.81%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.11%
- Depression: 3 people, 11.11%
- Constipation: 3 people, 11.11%
- Asthma: 3 people, 11.11%
- Pain In Extremity: 2 people, 7.41%
- High Blood Cholesterol: 2 people, 7.41%
- Back Pain: 2 people, 7.41%
* Approximation only. Some reports may have incomplete information.
Do you take Ditropan and Zelnorm?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Ditropan and Zelnorm:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ditropan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Zelnorm:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ditropan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Zelnorm and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on oxybutynin chloride and tegaserod maleate (the active ingredients of Ditropan and Zelnorm, respectively), and Ditropan and Zelnorm (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cimzia cause Nail Abnormalities? - 7 seconds ago
- Drug interactions of Rufinamide and Afinitor - 18 seconds ago
- Could Cytoxan cause Attention Deficit Hyperactivity Disorder? - 18 seconds ago
- Could Cytoxan cause Attention Deficit/Hyperactivity Disorder? - 19 seconds ago
- Could Fluocinolone Acetonide cause Blood Creatinine Increased? - 23 seconds ago
- Could Zofran cause Extravasation? - 24 seconds ago
- Could Warfarin Sodium cause Quadriplegia? - 34 seconds ago
- Could Warfarin Sodium cause Lactose Intolerance? - 43 seconds ago
- Could Warfarin Sodium cause Faeces Pale? - 53 seconds ago
- Could Juluca cause Stress And Anxiety? - 56 seconds ago